Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diphenhydramine for recovery complications after tympanoplasty
IRCT20150217021121N4Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of diphenhydramine in postoperative nausea and vomiting (PONV) and postoperative pain (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Severity of pain and Severity of nausea and vomiting. Started Apr 2020; status: completed.
02
Drugs
diphenhydramine
03
Conditions
postoperative nausea and vomiting (PONV)postoperative pain
Beyond the preview
Go deeper on IRCT20150217021121N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150217021121N4.